Clinical trial
The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity
NCT06489457 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity
- Lead sponsor
- University Medical Centre Ljubljana
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 20, 2020
- Completion date
- June 30, 2023
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
functional hypogonadism, obesity, type 2 diabetes mellitus